Medicare Enrolled

Dr. Stephen Bookbinder, M.D.

Rheumatology · Ocala, FL
Low-engagement
3210 SW 33RD RD, Ocala, FL 34474
3522377171
In practice since 2005 (20 years)
NPI: 1699767202 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bookbinder from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bookbinder? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bookbinder

Dr. Stephen Bookbinder is a rheumatology in Ocala, FL, with 20 years in practice.

Between the years covered by Open Payments, Dr. Bookbinder received a total of $7,782 from 30 pharmaceutical and/or device companies across 533 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bookbinder is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $7,782 industry payments

Industry Payment Transparency

Open Payments through 2022 ↗
$7,782
Total received (2018-2022)
Avg $1,556/year across 5 years
Top 47% in FL for rheumatology
30
Companies
533
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,721 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$61 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$1,554
2021
$1,450
2020
$1,627
2019
$1,882
2018
$1,269

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,287
UCB, Inc.
$802
Janssen Biotech, Inc.
$731
PFIZER INC.
$561
AbbVie Inc.
$545
AbbVie, Inc.
$541
E.R. Squibb & Sons, L.L.C.
$452
Horizon Therapeutics plc
$444
ABBVIE INC.
$440
Novartis Pharmaceuticals Corporation
$399
Genentech USA, Inc.
$345
GENZYME CORPORATION
$326
GlaxoSmithKline, LLC.
$195
Boehringer Ingelheim Pharmaceuticals, Inc.
$118
AstraZeneca Pharmaceuticals LP
$112
Radius Health, Inc.
$79
Mallinckrodt Hospital Products Inc.
$70
Lilly USA, LLC
$54
Janssen Pharmaceuticals, Inc
$49
Sobi, Inc
$42
SOBI, INC
$35
Bioventus LLC
$28
Horizon Pharma plc
$26
Actelion Pharmaceuticals US, Inc.
$18
Mallinckrodt LLC
$18
TerSera Therapeutics LLC
$17
Celgene Corporation
$16
Eisai Inc.
$12
West-Ward Pharmaceuticals
$12
Organon LLC
$8
Top 3 companies account for 36.2% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · COSENTYX · Cimzia · Dayvigo · Durolane · EVENITY · Enbrel · GELSYN-3 · HUMIRA · Humira · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · Mitigare · OFEV · OPSUMIT MACITENTAN · ORENCIA · Otezla · Prolia · Quzyttir · RAYOS · REMICADE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · TALTZ · TREMFYA · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology in Ocala?
Compare rheumatologys in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
2
Per 100K population
0.5
County median income
$58,535
Nearest hospital
ADVENTHEALTH OCALA
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2022
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bookbinder is a rheumatology, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Bookbinder receive payments from pharmaceutical companies?
Yes. Dr. Bookbinder received a total of $7,782 from 30 companies across 533 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Bookbinder) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Rheumatologys in Ocala
Browse rheumatologys in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologys in FL
Rheumatologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologys in FL
Which FL rheumatologys receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →